News in brief

Journal of Dietary Supplements plans special CBD issue

© Getty Images / MysteryShot
© Getty Images / MysteryShot

Related tags Cbd

The Journal of Dietary Supplements is planning a special issue devoted to the toxicology, pharmacology, and potential regulatory pathways for CBD and other cannabinoids, and is inviting submissions.

The issue, which will be published in May 2020, seeks to answer a number of questions, including: For which purposes is CBD effective? Is it safe? Is it safe for everyone? What should the future paths to market be for CBD as well as for other cannabinoids? Should CBD be allowed as a drug only, or is there a way for it to be listed as a dietary supplement and food ingredient?

Original, unpublished research manuscripts, including work performed in experimental models and clinical trials, as well as reviews and prospective papers are invited, and all papers will be peer-reviewed through a double-blind peer-review process.

Guidelines for submission to JDS can be found HERE​. Submitters are requested to indicate that manuscripts should be considered for the special issue on cannabidiol in your cover letter.

The deadline for submission is February 15, 2020.

Related topics Research Botanicals CBD / Hemp

Related news

Related products

show more

Consumers' growing demand for Omegas

Consumers' growing demand for Omegas

Content provided by Fruit d'Or | 13-Feb-2024 | White Paper

Consumers are increasingly interested in the benefits of omegas supplements. According to forecasts for 2023–2030, the global omega-3 market is expected...

Curcumin may support cognitive, brain & mood benefits

Curcumin may support cognitive, brain & mood benefits

Content provided by Verdure Sciences | 02-Feb-2024 | White Paper

Cognitive health, mental acuity and brain support categories have seen tremendous growth. With an aging population and increased interest from formulators...

Pomella® Extract: Prebiotic Potential in New Study

Pomella® Extract: Prebiotic Potential in New Study

Content provided by Verdure Sciences | 09-Jan-2024 | White Paper

A new clinical trial evaluated 250mg/day Pomella® for beneficial effects on the gut microbiome, circulating short chain fatty acids, and gut-microbial...

Related suppliers

Follow us

Products

View more

Webinars